Cara Therapeutics | CARA - Despesa De Juros Sobre A Dívida

Preço das Ações
2.90
Mudança Diária
-0.06 -2.03%
Mensal
-23.28%
Anual
-80.27%
Q2 Previsão
2.82




Despesa De Juros Sobre A Dívida Alterar Data
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Assertio Holdings USD 758K 1000 2024-06
Cara Therapeutics 39.02M 4.73M 2025-09
Cassava Sciences USD 129.73M 5.65M 2025-09
Chugai Pharma JPY 95M 260M 2025-12
Cipla INR 140.3M 8.5M 2025-12
Compugen USD 954K 116K 2025-09
CSL USD 215M 111M 2025-12
Grifols EUR 156.07M 31.46M 2025-09
Halozyme Therapeutics USD 4.91M 615K 2025-12
J&J USD 18M 290M 2025-09
Neurocrine Biosciences USD 1.1M 0 2024-03
Pacira USD 3.89M 387K 2025-12
Pfizer USD 711M 59M 2025-12
RedHill Biopharma USD 89.8K 31.69M 2024-06
Supernus Pharmaceuticals USD 910K 278K 2023-06
Vanda Pharmaceuticals 601.14M 23.61M 2025-09